Centre for Immunobiology: Recent submissions
Now showing items 421-440 of 1121
-
Host Gene Regulation by Transposable Elements: The New, the Old and the Ugly.
(2020-09-26)The human genome has been under selective pressure to evolve in response to emerging pathogens and other environmental challenges. Genome evolution includes the acquisition of new genes or new isoforms of genes and changes ... -
Proceedings of the Frontiers of Retrovirology Conference 2016
(Springer Nature, 2016-09) -
HMIC: Hierarchical medical image classification, a deep learning approach
(2020-06-12)© 2020 by the authors. Image classification is central to the big data revolution in medicine. Improved information processing methods for diagnosis and classification of digital medical images have shown to be successful ... -
Highlights from the 20th International Symposium on HIV and Emerging Infectious Diseases (ISHEID) 16-18 May 2018, Marseille, France: from HIV and comorbidities to global health.
(2018-07-01)The 20th International Symposium on HIV and Emerging Infectious Diseases took place in Marseille, France. It had a refreshing European look with reinforced partnerships with the European AIDS Clinical Society and the British ... -
Protocol for a human in vivo model of acute cigarette smoke inhalation challenge in smokers with COPD: monitoring the nasal and systemic immune response using a network biology approach
(BMJ Publishing Group Ltd, 2015-01-28)Introduction: Cigarette smoke contributes to a diverse range of diseases including chronic obstructive pulmonary disease (COPD), cardiovascular disorders and many cancers. There currently is a need for human challenge ... -
Surveillance of adverse events in the treatment of drug-resistant tuberculosis: first global report
(European Respiratory Society, 2019-12-19)WHO (World Health Organization) recommends countries to implement pharmacovigilance and to collect information on aDSM (active drug safety monitoring and management of adverse events-AEs). Aim of this prospective study ... -
Recombinant factor VIII Fc fusion protein for the treatment of severe haemophilia A: Final results from the ASPIRE extension study.
(Wiley, 2020-03-30)INTRODUCTION: The efficacy and safety of recombinant factor VIII Fc fusion protein (rFVIIIFc) as an extended half-life treatment for severe haemophilia A were demonstrated in the Phase 3 A-LONG and Kids A-LONG studies. ...